SYM FINANCIAL Corp Invests $346,000 in CVS Health Corporation (NYSE:CVS)

SYM FINANCIAL Corp acquired a new stake in CVS Health Corporation (NYSE:CVS - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 5,100 shares of the pharmacy operator's stock, valued at approximately $346,000.

Several other institutional investors have also modified their holdings of CVS. Essex Financial Services Inc. increased its position in CVS Health by 0.8% in the first quarter. Essex Financial Services Inc. now owns 20,705 shares of the pharmacy operator's stock worth $1,403,000 after purchasing an additional 166 shares during the period. McIlrath & Eck LLC boosted its stake in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock worth $32,000 after acquiring an additional 174 shares during the period. Sumitomo Life Insurance Co. boosted its holdings in shares of CVS Health by 1.0% during the first quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator's stock worth $1,159,000 after acquiring an additional 174 shares during the period. Koshinski Asset Management Inc. boosted its holdings in CVS Health by 3.7% in the 1st quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator's stock valued at $334,000 after purchasing an additional 178 shares during the period. Finally, Horizon Bancorp Inc. IN raised its stake in CVS Health by 7.4% in the first quarter. Horizon Bancorp Inc. IN now owns 2,610 shares of the pharmacy operator's stock valued at $177,000 after purchasing an additional 180 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company's stock.

Insider Buying and Selling

In related news, Director Guy P. Sansone purchased 1,570 shares of the business's stock in a transaction dated Thursday, June 5th. The shares were bought at an average price of $63.70 per share, with a total value of $100,009.00. Following the purchase, the director directly owned 12,007 shares in the company, valued at $764,845.90. This trade represents a 15.04% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. 1.22% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CVS. UBS Group lowered their target price on CVS Health from $71.00 to $67.00 and set a "neutral" rating for the company in a research report on Tuesday, July 22nd. Wall Street Zen upgraded shares of CVS Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Royal Bank Of Canada raised their price target on CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a report on Monday, May 5th. Barclays set a $79.00 target price on shares of CVS Health and gave the company an "overweight" rating in a research report on Monday, June 2nd. Finally, Jefferies Financial Group raised their price objective on CVS Health from $74.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, June 30th. Two equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $74.82.

CVS Health Trading Up 3.3%

Shares of CVS traded up $1.92 during trading hours on Friday, hitting $60.67. The stock had a trading volume of 10,876,795 shares, compared to its average volume of 6,441,933. The company's fifty day simple moving average is $64.61 and its 200 day simple moving average is $63.53. CVS Health Corporation has a 12-month low of $43.56 and a 12-month high of $72.51. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The firm has a market cap of $76.75 billion, a P/E ratio of 14.48, a P/E/G ratio of 0.87 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.62 by $0.63. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The company had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same quarter last year, the firm posted $1.31 EPS. The business's revenue for the quarter was up 7.0% on a year-over-year basis. Equities research analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Investors of record on Tuesday, July 22nd will be given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.38%. The ex-dividend date of this dividend is Tuesday, July 22nd. CVS Health's dividend payout ratio (DPR) is presently 63.48%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.